Skip to main content
CosIng Checker
CosIng Checker
EU cosmetic ingredients, restrictions and safety
Login
Annex II Entry 64 17/10/2010

Mofebutazone (INN)

Mofebutazone (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.

Search similar Back to annex Compare
Prohibited substance— Annex II, EU Regulation 1223/2009
Entry: 64

Chemical identity and properties

PubChem 2D chemical structure for CAS 2210-63-1
CAS 2210-63-1PubChem CID 16639

Mofebutazone

Mofebutazone is a pyrazolidine that is phenylbutazone lacking one of the phenyl substituents. It is used for treatment of joint and muscular pain. It has a role as a non-steroidal anti-inflammatory drug and a non-narcotic analgesic. — ChEBI

IUPAC name
4-butyl-1-phenylpyrazolidine-3,5-dione
Molecular formula
C13H16N2O2
Molecular weight
232.28 g/mol
Exact mass
232.121177757 Da
XLogP3
2.7
Topological polar surface area
49.4 Ų
Hydrogen-bond donors
1
Hydrogen-bond acceptors
2
Covalent units
1
Defined stereocentres
0

Also known as

MonophenylbutazoneMophebutazone2 FdbpMofebutazonaMofebutazonumMonazone4-Butyl-1-phenyl-3,5-pyrazolidinedione4-Butyl-1-phenyl-3,5-dioxopyrazolidine
16 more reported names
SPW36WUI5Z2-Phenyl-3,5-dihydroxy-4-butylpyrazolidineNSC-73725CHEBI:762521-phenyl-4-n-butyl-3,5-dioxopyrazolidineRefChem:159305M01AA02M02AA02218-641-1MobutazonMobuzonMobutazoneMonorheumettenMonazanMonobutylReumatox
Open full PubChem recordPubChem annotations3D structure image
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Record details

Chemical name

Mofebutazone (INN)

Regulatory information

Regulation

(EC) 2009/1223

See every entry this act set

Key data

CAS
2210-63-1
EC
218-641-1
Annex
II
Entry number
64

Direct matches are limited for this record, so nearby entries from Annex II are shown as well.

Annex II 62
Nearby record in the same annex

Brucine

CAS: 357-57-3
EC: 206-614-7
Annex II 70
Nearby record in the same annex

Cantharidine

CAS: 56-25-7
EC: 200-263-3

What Annex II means for Mofebutazone (INN)

Mofebutazone (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.

Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.

The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.

Compliance checklist

  • Verify this substance is absent from all raw materials and finished formulations.
  • Request absence confirmation or CoA from raw material suppliers.
  • Document the screening result in the Product Information File (PIF).

Frequently asked questions

Yes. Mofebutazone (INN) is listed in Annex II of EU Cosmetics Regulation 1223/2009 and is prohibited as an intentionally added cosmetic ingredient. Article 17 provides a narrow exception for unintended small quantities that are technically unavoidable under good manufacturing practice, provided the product remains safe under Article 3.

CAS 2210-63-1 is the unique numerical identifier assigned to Mofebutazone (INN) by the Chemical Abstracts Service. In cosmetic compliance work, the CAS number is used to cross-reference the substance across regulatory databases, raw material specifications and safety assessment reports. Multiple EU annex entries may share the same CAS number if the same substance appears under different conditions or in different annexes.

Use the INCI Checker tool on this site to paste your full ingredient list (INCI) and scan it against all Annex II–VI entries. The tool highlights any ingredients that match restricted, prohibited or allergen-flagged records. This is useful for rapid compliance screening of finished product formulas or raw material declarations.
Open INCI Checker

Source note for Annex II record Mofebutazone (INN)

This page summarizes one Annex II record for Mofebutazone (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.

Use this record page to review Annex II conditions for Mofebutazone (INN), but confirm any final regulatory decision against the current official annex wording and source files.

View sourcesView updates

Tools & next steps

Check your formula

Paste a full INCI list to detect Mofebutazone (INN) and other flagged EU annex records in one pass.

INCI Checker

Compare entries

Compare Mofebutazone (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.

Compare

Browse the annex

See all records in Annex II and compare regulatory conditions across substances in this annex.

Open Annex II